Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease
Introduction
Whereas delayed gastric emptying is believed to be a causative factor for producing delayed-on and motor fluctuation in Parkinson's disease (PD) [1], few studies have directly measured levodopa pharmacodynamics and gastric emptying together [2], [3]. In order to determine the relationship, we measured these two parameters in a single PD patients cohort.
Section snippets
Methods
Thirty-one patients who were diagnosed with PD [4] were enrolled in the study. They were 11 men and 20 women; age, 68.1 ± 7.8 years (mean ± standard deviation); disease duration, 4.2 ± 3.8 years; Modified Hoehn and Yahr stage 2.5 ± 0.71; Unified Parkinson's Disease Rating Scale (UPDRS) Part 3 Motor Score 18.37 ± 8.60; bowel movement < 3 times a week (constipation) in 20; all taking 301 mg ± 94 mg/day levodopa [as Menesit tablet [levodopa 100 mg/carbidopa 10 mg] in Japan]. Pharmacokinetic study was performed in
Results
Pharmacokinetic study showed that the plasma levodopa peak was at 2 hours in 42% (13/31 patients) whereas at 1 hour in 58% (18/31 patients), total of 50.7 ± 16.4 min (mean ± standard deviation) in all 31 patients (Fig. 1). The gastric emptying study showed that Tmax (13C) > 60 min was more common in patients with a plasma levodopa peak at 2 hours (14/18, 69%) than in those with a plasma levodopa peak at 1 hour (4/13, 22%) (p < 0.05) (Fig. 1).
The gastric emptying study also showed that 3 patients showed
Discussion
Previously, Evans et al. [2] measured gastric emptying time by 99mTc-diethyleletriamine-penta-acetic acid gastric scintigraphy and plasma levodopa concentration in 6 PD patients. However, he found no close relationship between these two parameters in his cohort. Dizdar et al. [3] administered the 13C-octanoic acid breath test and plasma levodopa concentration in one PD patient; he found delayed levodopa peak and slow gastric emptying time in this case. In the present study, we found a
Conflict of interest statement
None of the authors have conflict of interest.
Acknowledgments
Author contributions:
Hirokazu Doi has a role in acquisition, analysis and interpretation of data.
Ryuji Sakakibara has a role in study concept and design, acquisition of subjects and/or data, analysis and interpretation of data, and preparation of manuscript.
Mitsutoshi Sato has a role in acquisition of subjects and/or data.
Tohru Masaka has a role in acquisition of subjects and/or data.
Masahiko Kishi has a role in acquisition of subjects and/or data.
Akihiko Tateno has a role in acquisition of
References (12)
- et al.
Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test
Gastroenterology
(1993) - et al.
Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia
Gastroenterology
(2004) Multi-organ autonomic dysfunction in Parkinson disease
Parkinsonism Relat Disord
(2011)- et al.
Levodopa ameliorated anorectal constipation in de novo Parkinson's disease: the QL-GAT study
Parkinsonism Relat Disord
(2011) - et al.
Management of motor complications in advanced Parkinson's disease
Mov Disord
(2007) - et al.
Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient
Neurology
(1981)